Higher expression of metalloproteinases (MMPs) has been shown in breast cancer cells, and a correlation of reduced TFPI-2 levels with increased expression of MMP-2 mRNA was reported in pancreatic cancers14,18. This evidence concerns the gene TFPI2 and breast carcinoma.